About UsNewsShop
Fighting hereditary breast and ovarian cancer
FORCE Events
| More

PARP Inhibitor Research Update

image top

Upcoming Webinar

Please join us for our next on-line seminar for people affected by hereditary breast and ovarian cancer.

Be Empowered Webinars

image bottom

June 27, 2013

Presenter: Susan Domchek, MD, Executive Director of the Basser Research Center for BRCA 
Description: Due to overwhelming demand, our next webinar will cover PARP inhibitor research updates, including the latest research from the American Society of Clinical Oncology (ASCO) conference. Medical oncologist and researcher Susan Domcheck, MD, Executive Director of the Basser Research Center for BRCA as she explains more about the state of research on these drugs.

More on PARP inhibitors

Read more about PARP inhibitors in our Spring 2013 Newsletter
BROCADE is a PARP inhibitor clinical trial for advanced, BRCA-associated breast cancer


Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.

Privacy Policy | Sitemap | Contact Us

Morphtek

This site has been made possible by a generous grant from Morphotek.


Web design by Rareheron Web Design

copyright © FORCE: Facing Our Risk of Cancer Empowered, Inc.  •  info@facingourrisk.org